Cure Genetics Co., Ltd., a biotechnology company dedicated to the development of life-saving transformative medicines an...
IMPACT Therapeutics a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of...
Laekna Inc., a biotechnology company headquartered in Shanghai has announced the signing of an agreement with Novartis P...
Legend Capital, the venture and growth capital arm of China’s Legend Holdings Ltd, has co-led an RMB2 billion ($29...
Chinese medical solution provider Medlinker has raised a RMB1 billion ($146.8 million) series D round led by China Capit...
Ascletis has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new ...
Orig3n, Inc., a Boston-based biotech company pioneering the future of health through genetics and regenerative medicine,...
Ascletis announced that the Ganovo phase III clinical study won the top clinical research award at the 15th National Con...
Shanghai-based biopharma firm Curon Biopharmaceutical has announced the completion of its Series A funding round, which ...
China Stem Cell Group Co Ltd, a Shanghai-based company has announced the opening of its affiliated stem cell hospital in...
Omniome, Inc., US based developer of an innovative new DNA sequencing platform, has raised an additional $60 million wit...
Merck known as MSD outside the United States and Canada has announced that KEYTRUDA Merck’s anti-PD-1 therapy, has...
HitGen, a biotech company with headquarters and main research facilities based in Chengdu, China, and with facilities in...
China based I-Mab Biopharma, a company focusing on innovative biologics in immuno-oncology and immuno-inflammation, and ...
STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredie...
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and intends to commercialize high ...
Terumo Corporation recently announced that it has entered into an agreement to acquire Essen Technology (Beijing) Co., L...
Bristol-Myers Squibb (BMS) has formed a new collaboration with Beijing's Tsinghua University to develop drugs for novel ...
